Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Milled vs 3D-Printed Partial-Coverage Restorations in Endodontically Treated Molars

9 de junio de 2026 actualizado por: Tomás Yoma Galleguillos, Hospital San Jose

Clinical Performance of CAD/CAM-Milled Versus 3D-Printed Composite Resin Partial-Coverage Restorations for Endodontically Treated Molars: A Randomized Controlled Clinical Trial

The goal of this clinical trial is to compare the clinical performance of Computer-Aided Design and Computer-Aided Manufacturing (CAD/CAM)-milled and 3D-printed composite resin partial-coverage restorations in endodontically treated molars.

The main questions it aims to answer are:

  • Do 3D-printed composite resin partial-coverage restorations show similar clinical performance compared with CAD/CAM-milled composite resin restorations?
  • Are there differences in survival, success rates, and complications between the two types of restorations over a 3-year follow-up period?

Researchers will compare CAD/CAM-milled composite resin restorations with 3D-printed composite resin restorations to evaluate their clinical performance.

Participants will:

  • Receive a partial-coverage restoration (onlay or overlay) in an endodontically treated molar.
  • Be randomly assigned to receive either a CAD/CAM-milled or a 3D-printed composite resin restoration.
  • Attend follow-up visits at 12, 24, and 36 months.
  • Undergo clinical evaluations by two blinded evaluators using the revised FDI criteria and standardized photographic documentation.

Descripción general del estudio

Descripción detallada

This randomized controlled clinical trial evaluates the clinical performance of indirect composite resin partial-coverage restorations fabricated using subtractive and additive manufacturing technologies in endodontically treated molars.

The study investigates whether 3D-printed composite resin restorations can achieve clinical outcomes comparable to CAD/CAM-milled composite resin restorations when used for cuspal coverage of structurally compromised posterior teeth.

All restorations will be fabricated using a fully digital workflow. Tooth preparation, immediate dentin sealing, digital intraoral scanning, restoration fabrication, and adhesive cementation procedures will be standardized and performed according to a predefined clinical protocol.

The trial will be conducted at Hospital San José, Santiago, Chile, using commercially available restorative materials manufactured by subtractive and additive technologies. Clinical performance will be evaluated according to internationally accepted restorative assessment criteria.

The study aims to generate medium-term clinical evidence regarding the use of 3D-printed composite resin restorations as a potential alternative to conventional CAD/CAM-milled restorations in restorative dentistry.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

142

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Tomás Yoma Galleguillos, DDS
  • Número de teléfono: +56985768407
  • Correo electrónico: tomasyoma@gmail.com

Ubicaciones de estudio

    • Santiago Metropolitan
      • Santiago, Santiago Metropolitan, Chile
        • Reclutamiento
        • Hospital San Jose
        • Contacto:
          • Tomás Yoma Galleguillos, DDS
          • Número de teléfono: +56985768407
          • Correo electrónico: tomasyoma@gmail.com
        • Investigador principal:
          • Tomás Yoma Galleguillos, DDS

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Adults aged 18 to 70 years
  • Absence of active periodontal disease
  • Good oral hygiene (O'Leary plaque index <20%)
  • Absence of parafunctional habits (e.g., bruxism, onychophagia)
  • Endodontically treated first molars (maxillary or mandibular) with extensive Class II cavities and loss of at least one cusp, requiring onlay or overlay restoration
  • Tooth with functional occlusal contact and at least one proximal contact
  • Referred from the Endodontics Department of Hospital San José, with endodontic treatment completed at the same institution
  • Ability to provide written informed consent
  • Ability to attend follow-up visits at 12, 24, and 36 months

Exclusion Criteria:

  • Untreated active periodontal disease
  • Poor oral hygiene (O'Leary plaque index ≥20%)
  • Generalized active caries
  • Active parafunctional habits
  • Teeth with complete circumferential structural destruction or insufficient coronal tooth structure for onlay/overlay restoration
  • Subgingival margins compromising the biologic width
  • Known allergy to study materials
  • Pregnancy or breastfeeding

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Comparador activo: Milled Composite Resin Onlay/Overlay
Participants receive indirect onlay or overlay restorations fabricated from milled composite resin blocks (HC Block, Shofu, Japan) for the rehabilitation of endodontically treated molars with extensive loss of tooth structure. Tooth preparation, immediate dentin sealing, digital impression, and adhesive cementation procedures are standardized for all participants
Indirect partial coverage restoration fabricated from milled composite resin blocks (HC Block, Shofu, Japan) and adhesively cemented on endodontically treated molars.
Experimental: 3D-Printed Composite Resin Onlay/Overlay
Participants receive indirect onlay or overlay restorations fabricated from 3D-printed composite resin (Rodin Sculpture, Pac-Dent, USA) for the rehabilitation of endodontically treated molars with extensive loss of tooth structure. Tooth preparation, immediate dentin sealing, digital impression, and adhesive cementation procedures are standardized for all participants.
Indirect partial coverage restoration fabricated from 3D-printed composite resin (Rodin Sculpture, Pac-Dent, USA) and adhesively cemented on endodontically treated molars.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Clinical performance of onlay and overlay restorations according to revised World Dental Federation (FDI) criteria.
Periodo de tiempo: Baseline, 12 months, 24 months, and 36 months (primary endpoint at 36 months)
Clinical performance of milled and 3D-printed composite resin onlay and overlay restorations assessed using the revised FDI criteria. An overall FDI evaluation score will be assigned to each restoration by two blinded evaluators.
Baseline, 12 months, 24 months, and 36 months (primary endpoint at 36 months)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Restoration survival rate
Periodo de tiempo: 36 months
Survival of milled and 3D-printed composite resin onlay and overlay restorations. A restoration will be considered surviving if it remains in function at follow-up, regardless of the need for minor repair.
36 months
Restoration success rate
Periodo de tiempo: 36 months
Success of restorations according to revised FDI criteria. Restorations receiving clinically acceptable ratings and not requiring corrective intervention will be considered successful.
36 months
Restoration failure rate
Periodo de tiempo: 36 months
Proportion of restorations requiring replacement during the 36-month follow-up period.
36 months
Clinical complications
Periodo de tiempo: Baseline to 36 months
Frequency and type of clinical complications observed during the 36-month follow-up period, including mechanical, biological, and esthetic complications associated with the restorations.
Baseline to 36 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Tomás Yoma Galleguillos, DDS, Hospital San José, Santiago, Chile

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

29 de mayo de 2026

Finalización primaria (Estimado)

31 de mayo de 2030

Finalización del estudio (Estimado)

30 de junio de 2030

Fechas de registro del estudio

Enviado por primera vez

2 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

9 de junio de 2026

Publicado por primera vez (Actual)

11 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

11 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

9 de junio de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Individual participant data will not be shared with other researchers due to confidentiality and privacy considerations related to patient information.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir